IPO - Alpha Teknova, Inc.

Form Type: S-3

Filing Date: 2025-07-10

Corporate Action: Ipo

Type: New

Accession Number: 000119312525157628

Filing Summary: Alpha Teknova, Inc., a Delaware corporation, filed a registration statement under the Securities Act of 1933 on July 10, 2025, for offering up to $225,000,000 of various securities including common stock, preferred stock, debt securities, warrants, rights, and units. This registration statement incorporates by reference other reports filed by the company with the SEC, providing investors with financial state insights and operational conditions. The Company leverages its sophisticated manufacturing processes to create custom reagents essential for life sciences, showing potential for growth in areas like mRNA vaccine development and gene therapies. The firm has a robust market presence with high customer retention rates and has been operational since 1996, conducting an IPO in 2021. The document outlines the risks associated with the securities and stipulates that proceeds will be used for working capital, operational enhancements, and potential business combinations. Alpha Teknova operates an emerging growth company status, allowing it to benefit from streamlined reporting requirements. The last reported sales price for its common stock was $5.28 per share as of July 9, 2025, and the company emphasizes the importance of GMP-compliant production for future growth.